NCT06063174

Brief Summary

Goal 1: The investigators will quantify lifetime stress burden and examine mechanisms linking Adverse Childhood Experiences (ACEs) and health. The investigators will quantify the early life and total lifetime stress burden of a representative sample of about 725 adults (aged 18+) across northern and southern California. In addition, the investigators will examine how prior life stress exposure and current stress levels are associated with differences in psychosocial, immune, metabolic, physiologic, and clinical outcomes for all participants at baseline. Goal 2: The investigators will develop and test a biopsychosocial intervention using existing programs, platforms, resources, and core components from trauma and resilience research that will target five stress-related domains (i.e., cognitive response style, social relationships, eating, sleep, and physical activity) using cognitive restructuring and mindfulness, interpersonal skills training, mindful eating training, sleep training, and behavioral activation/mobility training. The investigators will then assess the efficacy and acceptability of the intervention in about 425 high stress exposure participants from Goal 1. Following their baseline assessment, about 425 participants will be randomly assigned to receive for 12 weeks (a) personalized intervention, (b) environmental education (active control) or (c) nothing (non-active control). The investigators will also assess the efficacy of the personalized intervention by comparing changes in outcomes by condition from baseline (prior to randomization) to immediately after the intervention, and then again after 12 weeks following intervention completion. The interventions will be entirely online/remote.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
712

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 30, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 6, 2023

Completed
26 days until next milestone

First Posted

Study publicly available on registry

October 2, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2024

Completed
Last Updated

April 15, 2025

Status Verified

September 1, 2024

Enrollment Period

1.3 years

First QC Date

September 6, 2023

Last Update Submit

April 10, 2025

Conditions

Keywords

StressImmunologyPsychosocialClinicalResilience

Outcome Measures

Primary Outcomes (1)

  • Change in PSS-10

    The primary endpoint will be the change in Perceived Stress Scale (PSS-10) score between the nonactive control, active control, and the treatment groups (combined) from screening to Follow-up 1 \& 2. A meaningful clinically significant score in the PSS-10 score is a difference of 5 points. The range of the PSS-10 is 0-40, with higher scores indicating more perceived stress. As such PSS-10 change scores could range from -40 to 40. A positive PSS-10 change score indicates increased stress and is a negative outcome. A negative PSS-10 change score indicates decreased stress and is a positive outcome.

    PSS-10 will be assessed at all three time points during the baseline period (first 1-3 weeks of the study), follow-up1 (after 12-week intervention), and follow-up2 (at 24 week mark from baseline).

Secondary Outcomes (6)

  • Change in CSS subscale Score

    Consequences of Stress scale will be assessed at all three time points during the baseline period (first 1-3 weeks of the study), follow-up1 (after 12-week intervention), and follow-up2 (at 24 week mark from baseline).

  • Change in Five-Factor Mindfulness Scale short form (cognitive response style domain)

    Five-Factor Mindfulness scale will be assessed at all three time points during the baseline period (first 1-3 weeks of the study), follow-up1 (after 12-week intervention), and follow-up2 (at 24 week mark from baseline).

  • Change in Conflict Scale and UCLA Loneliness Scale (social relationship domain)

    Five-Factor Mindfulness scale will be assessed at all three time points during the baseline period (first 1-3 weeks of the study), follow-up1 (after 12-week intervention), and follow-up2 (at 24 week mark from baseline).

  • Change in Salzburg Stress Eating Scale (eating domain)

    Salzburg Stress Eating scale will be assessed at all three time points during the baseline period (first 1-3 weeks of the study), follow-up1 (after 12-week intervention), and follow-up2 (at 24 week mark from baseline).

  • Change in Insomnia Severity Index (sleeping domain)

    Insomnia Severity Index scale will be assessed at all three time points during the baseline period (first 1-3 weeks of the study), follow-up1 (after 12-week intervention), and follow-up2 (at 24 week mark from baseline).

  • +1 more secondary outcomes

Study Arms (4)

Baseline-Only

NO INTERVENTION

Baseline-only condition will be cross-sectional, and participants will be only completing the first portion of the study. Participants in this arm will be asked to wear a research-grade smartwatch for at least one week and complete the baseline package at one time point which includes self-reported questionnaires, micro-blood collection, and optional stool collection.

Active Control

ACTIVE COMPARATOR

Active control condition will be longitudinal. Participants in this arm will be asked to wear a research-grade smartwatch for at least 24 weeks and complete the baseline package as well as two follow-ups over a period of 24 weeks. After completing the baseline package, participants in the active control group will receive a 12 week psychoeducation training on stress and health called the Environmental Education Program.

Behavioral: Education Program

Nonactive Control

NO INTERVENTION

Nonactive control condition will be longitudinal. Participants in this arm will be asked to wear a research-grade smartwatch for at least 24 weeks and complete the baseline package as well as two follow-ups over a period of 24 weeks. After completing the baseline package, participants in the nonactive control group will not be receiving any forms of intervention. Participants in this program called the Follow-up Program will be tracked over 12 weeks in parallel to participants receiving an intervention and another 12 weeks after.

CAL STAR Personalized Intervention

EXPERIMENTAL

CAL STAR Personalized Intervention condition will be longitudinal. Participants in this arm will be asked to wear a research-grade smartwatch for at least 24 weeks and complete the baseline package as well as two follow-ups over a period of 24 weeks. After completing the baseline package, participants will be assigned to one of the five CAL STAR Personalized Intervention training programs (Think Well, Be Well, Eat Well, Sleep Well, Move Well programs) depending on their score on a self-reported survey called Consequences of Stress Scale (CSS). Based on the CSS score, a participant will be assigned to one of the five programs to work on a domain that is dysregulated when they are stressed. When eligible for multiple, their availability to attend coaching sessions and preferences will be accounted for, or they will be randomly assigned to conditions for which they are eligible.

Behavioral: Think Well ProgramBehavioral: Be Well ProgramBehavioral: Eat Well ProgramBehavioral: Sleep Well ProgramBehavioral: Move Well Program

Interventions

12-week online psychoeducation program on environmental pollution exposures, the health impacts and sources of these exposures, and practical ways to reduce these exposures. Participants in the active control group will receive this form of intervention.

Active Control

12-week online program in which participants learn to identify negative emotion and thinking patterns and participate in live online group coaching. Participants whose thinking style domain is dysregulated will be assigned to this intervention program.

CAL STAR Personalized Intervention
Be Well ProgramBEHAVIORAL

12-week online program in which participants learn about the importance of social relationships, connectedness, and interpersonal conflicts, and participate in live online group coaching. Participants whose social relationship/conflict domain is dysregulated will be assigned to this intervention program.

CAL STAR Personalized Intervention

12-week online program in which participants learn about mindful eating and participate in live online group coaching. Participants whose diet domain is dysregulated will be assigned to this intervention program.

CAL STAR Personalized Intervention

12-week online program in which participants learn about the importance of good sleep and participate in live online group coaching. Participants whose sleep domain is dysregulated will be assigned to this intervention program.

CAL STAR Personalized Intervention

12-week online program in which participants learn about the importance of adequate physical activity for health and participate in live online group coaching. Participants whose physical activity domain is dysregulated will be assigned to this intervention program.

CAL STAR Personalized Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A participant must meet all of the following criteria to be eligible to participate in this study:
  • Be able to understand and agree to comply with planned study procedures in English.
  • Participants must be aged 18 or over.
  • Participants must reside in the state of California.

You may not qualify if:

  • A participant who meets any of the following criteria will be excluded from participation in this study:
  • History of disease(s):
  • Has a positive test result for human immunodeficiency virus (HIV) types 1 or 2 antibodies.
  • Has had a heart attack or stroke within the past year.
  • Has had and/or been treated for any type of cancer in the past two years.
  • Medication(s):
  • Participants who check off any of the following medications and/or treatment listed below over the past month will be excluded in the study.
  • Prednisolone (e.g., Omnipred, Pred Mild, Pred Forte, Orapred ODT, Veripred 20, Millipred DP)
  • Prednisone (e.g., Prednisone Intensol, Deltasone, Rayos)
  • Betamethasone (e.g., Celestone Soluspan, Sernivo, Diprolene AF, ReadySharp Betamethasone, Betaloan SUIK, Beta-1)
  • Dexamethasone (e.g., Ozurdex, Maxidex, DexPak 6 Day/10 day/13 Day, LoCort, ZonaCort, ReadySharp dexamethasone, DoubleDex)
  • Hydrocortisone (e.g., Hydrocort, Alphosyl, Aquacort, Cortef, Cortenema, and Solu-Cortef)
  • Methylprednisolone (e.g., Depo-Medrol, Solu-Medrol, Medrol, ReadySharp Methylprednisolone, P-Care D80, and P-Care D40)
  • Deflazacort (e.g., Emflaza)
  • Immunomodulators
  • +15 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, Los Angeles

Los Angeles, California, 90024, United States

Location

Related Publications (25)

  • Hughes K, Bellis MA, Hardcastle KA, Sethi D, Butchart A, Mikton C, Jones L, Dunne MP. The effect of multiple adverse childhood experiences on health: a systematic review and meta-analysis. Lancet Public Health. 2017 Aug;2(8):e356-e366. doi: 10.1016/S2468-2667(17)30118-4. Epub 2017 Jul 31.

    PMID: 29253477BACKGROUND
  • California Department of Public Health and Department of Social Services. Adverse Childhood Experiences Data Report: Behavioral Risk Factor Surveillance System (BRFSS), 2011-2017: An Overview of Adverse Childhood Experiences in California. (2020). doi:10.48019/PEAM8812.

    BACKGROUND
  • Hargreaves MK, Mouton CP, Liu J, Zhou YE, Blot WJ. Adverse Childhood Experiences and Health Care Utilization in a Low-Income Population. J Health Care Poor Underserved. 2019;30(2):749-767. doi: 10.1353/hpu.2019.0054.

    PMID: 31130549BACKGROUND
  • Birn RM, Roeber BJ, Pollak SD. Early childhood stress exposure, reward pathways, and adult decision making. Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):13549-13554. doi: 10.1073/pnas.1708791114. Epub 2017 Dec 4.

    PMID: 29203671BACKGROUND
  • Slavich GM. Social Safety Theory: A Biologically Based Evolutionary Perspective on Life Stress, Health, and Behavior. Annu Rev Clin Psychol. 2020 May 7;16:265-295. doi: 10.1146/annurev-clinpsy-032816-045159. Epub 2020 Mar 6.

    PMID: 32141764BACKGROUND
  • Slavich GM, Way BM, Eisenberger NI, Taylor SE. Neural sensitivity to social rejection is associated with inflammatory responses to social stress. Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14817-22. doi: 10.1073/pnas.1009164107. Epub 2010 Aug 2.

    PMID: 20679216BACKGROUND
  • Cohodes EM, Kitt ER, Baskin-Sommers A, Gee DG. Influences of early-life stress on frontolimbic circuitry: Harnessing a dimensional approach to elucidate the effects of heterogeneity in stress exposure. Dev Psychobiol. 2021 Mar;63(2):153-172. doi: 10.1002/dev.21969. Epub 2020 Mar 29.

    PMID: 32227350BACKGROUND
  • Gee DG, Casey BJ. The Impact of Developmental Timing for Stress and Recovery. Neurobiol Stress. 2015 Jan 1;1:184-194. doi: 10.1016/j.ynstr.2015.02.001.

    PMID: 25798454BACKGROUND
  • Miller TR, Waehrer GM, Oh DL, Purewal Boparai S, Ohlsson Walker S, Silverio Marques S, Burke Harris N. Adult health burden and costs in California during 2013 associated with prior adverse childhood experiences. PLoS One. 2020 Jan 28;15(1):e0228019. doi: 10.1371/journal.pone.0228019. eCollection 2020.

    PMID: 31990957BACKGROUND
  • Waehrer GM, Miller TR, Silverio Marques SC, Oh DL, Burke Harris N. Disease burden of adverse childhood experiences across 14 states. PLoS One. 2020 Jan 28;15(1):e0226134. doi: 10.1371/journal.pone.0226134. eCollection 2020.

    PMID: 31990910BACKGROUND
  • Bhushan D, Kotz K, McCall J, etal. Road map for Resilience: The California Surgeon General's Report on Adverse Childhood Experiences, Toxic Stress, and Health.(2020). doi:10.48019/PEAM8812

    BACKGROUND
  • Giano Z, Wheeler DL, Hubach RD. The frequencies and disparities of adverse childhood experiences in the U.S. BMC Public Health. 2020 Sep 10;20(1):1327. doi: 10.1186/s12889-020-09411-z.

    PMID: 32907569BACKGROUND
  • Dwyer-Lindgren L, Bertozzi-Villa A, Stubbs RW, Morozoff C, Mackenbach JP, van Lenthe FJ, Mokdad AH, Murray CJL. Inequalities in Life Expectancy Among US Counties, 1980 to 2014: Temporal Trends and Key Drivers. JAMA Intern Med. 2017 Jul 1;177(7):1003-1011. doi: 10.1001/jamainternmed.2017.0918.

    PMID: 28492829BACKGROUND
  • Stork BR, Akselberg NJ, Qin Y, Miller DC. Adverse Childhood Experiences (ACEs) and Community Physicians: What We've Learned. Perm J. 2020;24:19.099. doi: 10.7812/TPP/19.099. Epub 2020 Jan 24.

    PMID: 32069204BACKGROUND
  • Valderhaug TG, Slavich GM. Assessing Life Stress: A Critical Priority in Obesity Research and Treatment. Obesity (Silver Spring). 2020 Sep;28(9):1571-1573. doi: 10.1002/oby.22911. Epub 2020 Jul 29.

    PMID: 32729167BACKGROUND
  • Chambers DA, Norton WE. The Adaptome: Advancing the Science of Intervention Adaptation. Am J Prev Med. 2016 Oct;51(4 Suppl 2):S124-31. doi: 10.1016/j.amepre.2016.05.011. Epub 2016 Jun 28.

    PMID: 27371105BACKGROUND
  • Wang YA, Rhemtulla M. Power analysis for parameter estimates in structural equation modeling:A discussion and tutorial. Adv Methods Pract Psychol Sci. doi:10.31234/osf.io/pj67b

    BACKGROUND
  • Shields GS, Spahr CM, Slavich GM. Psychosocial Interventions and Immune System Function: A Systematic Review and Meta-analysis of Randomized Clinical Trials. JAMA Psychiatry. 2020 Oct 1;77(10):1031-1043. doi: 10.1001/jamapsychiatry.2020.0431.

    PMID: 32492090BACKGROUND
  • Kivimaki M, Steptoe A. Effects of stress on the development and progression of cardiovascular disease. Nat Rev Cardiol. 2018 Apr;15(4):215-229. doi: 10.1038/nrcardio.2017.189. Epub 2017 Dec 7.

    PMID: 29213140BACKGROUND
  • Truelsen T, Nielsen N, Boysen G, Gronbaek M; Copenhagen City Heart Study. Self-reported stress and risk of stroke: the Copenhagen City Heart Study. Stroke. 2003 Apr;34(4):856-62. doi: 10.1161/01.STR.0000062345.80774.40. Epub 2003 Mar 13.

    PMID: 12637696BACKGROUND
  • Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull. 2014 May;140(3):774-815. doi: 10.1037/a0035302. Epub 2014 Jan 13.

    PMID: 24417575BACKGROUND
  • Chiang JJ, Park H, Almeida DM, Bower JE, Cole SW, Irwin MR, McCreath H, Seeman TE, Fuligni AJ. Psychosocial stress and C-reactive protein from mid-adolescence to young adulthood. Health Psychol. 2019 Mar;38(3):259-267. doi: 10.1037/hea0000701.

    PMID: 30762405BACKGROUND
  • Weyh C, Kruger K, Strasser B. Physical Activity and Diet Shape the Immune System during Aging. Nutrients. 2020 Feb 28;12(3):622. doi: 10.3390/nu12030622.

    PMID: 32121049BACKGROUND
  • Barton W, Penney NC, Cronin O, Garcia-Perez I, Molloy MG, Holmes E, Shanahan F, Cotter PD, O'Sullivan O. The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level. Gut. 2018 Apr;67(4):625-633. doi: 10.1136/gutjnl-2016-313627. Epub 2017 Mar 30.

    PMID: 28360096BACKGROUND
  • Adamantidis A, de Lecea L. Sleep and metabolism: shared circuits, new connections. Trends Endocrinol Metab. 2008 Dec;19(10):362-70. doi: 10.1016/j.tem.2008.08.007. Epub 2008 Oct 18.

    PMID: 18938086BACKGROUND

MeSH Terms

Conditions

Stress, PsychologicalFractures, Stress

Interventions

Early Intervention, Educational

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorFractures, BoneWounds and Injuries

Intervention Hierarchy (Ancestors)

Child Health ServicesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesPreventive Health Services

Study Officials

  • George M Slavich, PhD

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR
  • Michael P Snyder, PhD

    Stanford University

    PRINCIPAL INVESTIGATOR
  • Alicia F Lieberman, PhD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR
  • Shannon Thyne, MD

    Los Angeles County Department of Public Health

    PRINCIPAL INVESTIGATOR
  • Patricia E Lester, MD

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR
  • Atul J Butte, MD,PhD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lead Principal Investigator

Study Record Dates

First Submitted

September 6, 2023

First Posted

October 2, 2023

Study Start

June 30, 2023

Primary Completion

October 30, 2024

Study Completion

October 30, 2024

Last Updated

April 15, 2025

Record last verified: 2024-09

Locations